A 12-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2599506 in Patients With Type 2 Diabetes Mellitus Treated With Diet and Exercise, With or Without Metformin.
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2012
At a glance
- Drugs PSN 010 (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 24 Jun 2010 Actual patient number (40) added as reported by ClinicalTrials.gov.
- 24 Jun 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.